The USP6 gene helps control how cells grow, move, and respond to signals inside the body. The protein made by this gene helps your cells fine tune growth signals, and when the USP6 gene is switched on too strongly, some bone or soft tissue cells can form fast growing but usually noncancerous growths such as aneurysmal bone cysts or nodular fasciitis. In medicine, the USP6 gene is best known for its role in identifying these growths.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate activities in the body. Some genes provide the instructions for producing proteins, which are the functional parts of cells. Others mainly help direct when certain processes take place, where they occur, and how strongly they run. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. To explore this topic in more detail, you can learn more in the LearnHub.
Overview
USP6Gene function
What if the gene works
The USP6 gene gives cells instructions for a protein that helps remove small chemical tags from other proteins. This helps control cell signaling, protein recycling, and normal cell growth.
Risk
What if the gene does not work
Changes that raise activity of the USP6 gene can drive aneurysmal bone cysts and nodular fasciitis. Milder or more pronounced changes may influence which tissue is affected and how quickly the growth appears, but these growths are usually noncancerous.
Treatment
What does that mean for your treatment
No USP6-specific treatment or drug choice approach is currently established for pathogenic variants in the USP6 gene. USP6 is being studied as a biologic driver and biomarker in certain bone and soft tissue lesions, but this has not yet led to guideline-based targeted treatment.
Conditions associated with USP6
Gene function
What if the gene works
In your cells, the USP6 gene helps manage everyday protein signals and internal transport. It does this by removing small control tags from selected proteins, which can change how long they stay active or where they move. Understanding the USP6 gene's role in cell signaling and protein recycling helps show how cells keep routine processes organized.
The USP6 gene makes a protein that removes ubiquitin, a small tag cells use to direct other proteins. This helps control whether certain proteins stay active, get recycled, or move to a new place.
By adjusting these protein tags, the USP6 gene helps fine tune signals that guide cell communication and day to day activity. It supports more controlled responses when cells react to their surroundings.
This gene also supports endocytosis (the process cells use to bring in and sort material from their surface). This supports protein recycling and the movement of materials inside cells.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help explain normal variation among people, including traits such as appearance, metabolism, or the way the body reacts to environmental influences. Many variants do not lead to any noticeable changes and are simply part of natural genetic diversity. Sometimes, though, a variant affects how a gene works more strongly and may play a role in or directly cause a genetic condition.
Genetic variants
What if the gene does not work
Most USP6-related variants change how the USP6 gene is controlled rather than damaging the protein itself. In many cases, a DNA rearrangement places USP6 next to a stronger on switch, so cells make too much USP6 protein; this is how USP6 gene variants affect cells at the molecular level. Milder changes may raise activity less, while stronger rearrangements can drive greater cell signaling and faster tissue overgrowth, which may influence how prominent or early a USP6-associated growth becomes.
How variants are linked to conditions
How USP6 gene variants are linked to conditions is most clearly seen in aneurysmal bone cysts, where rearrangements of the USP6 gene can confirm the diagnosis. Variants involving the USP6 gene are also found in nodular fasciitis and some related benign bone or soft tissue growths. These changes are usually acquired in the affected tissue and are not typically inherited through families.
A variant is not necessarily a diagnosis
Genetic variants are a usual feature of human biology and are widely found in the general population. Most do not directly affect health and instead reflect normal human diversity. For many genes, having a variant linked to a condition indicates a possible association rather than a confirmed diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the USP6 gene. In most cases, changes involving USP6 are not inherited and are not linked to day-to-day lifestyle factors.
Inheritance of USP6 variants
For most people, the USP6 inheritance pattern is not a classic inherited pattern tied to a single well-established genetic condition. Changes involving the USP6 gene are most often found only in affected tissue and are not usually passed from parent to child. The USP6 gene is located on chromosome 17, which is an autosome, so each person inherits one copy from each parent. In day to day terms, this means a USP6 variant found in a growth or lesion usually does not mean other family members inherited the same change.
What does my USP6 result mean for my family?
There isn’t yet a broadly confirmed inherited pattern tied to a specific health condition for USP6. Most known USP6-related changes are not the kind that clearly run in families, so a USP6 result usually does not by itself suggest that relatives are at the same genetic risk.
Genetic information
Genetic testing
How you find out about variants
USP6 genetic testing usually uses a biopsy sample from the growth, because these variants are often acquired in the tissue rather than inherited and present in blood or saliva. Labs look for USP6 rearrangements, where DNA is joined to the wrong partner, with tests that read the gene or check how it is arranged.
When should I consider getting a genetic test?
Testing for USP6 is usually considered when a doctor is trying to confirm the cause of a bone or soft-tissue growth, such as an aneurysmal bone cyst or nodular fasciitis. In these cases, the test is often done on the growth itself, not on a blood sample, because USP6 changes are usually not inherited.
A genetic result is only one part of your health story
Genetic results can provide meaningful information, but how much they explain depends on the condition and the type of variant involved. How the body works over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help place individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment, yet one may get the expected benefit while another may notice less effect or more side effects. One reason is that the body absorbs, breaks down, transports, and responds to drugs a little differently from person to person. This kind of variation is common and can influence how well a medication works or how sensitive someone is to it.
What is Pharmacogenetics?
Pharmacogenetics looks at how differences in genes can affect a person’s response to medicines. It examines the links between genes and drugs to better explain why the same treatment may work differently from one person to another. For many medications, genes influence how the body handles a drug or how strong its effects are. This information can support more informed, more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the USP6 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choice or dose. Questions about treatment, side effects, or new symptoms are best discussed with your doctor or pharmacist.
History
The USP6 gene entered medical genetics through studies of unusual bone growths, especially aneurysmal bone cysts, where recurring chromosome rearrangements pointed researchers to the same gene. Initially described in cancer research under the name TRE2, it was later recognized as the USP6 gene as scientists clarified where it fit in the human genome. From these first observations, research expanded steadily. This work helped show that some growths once thought to be purely reactive were actually driven by specific genetic changes. Over time, the USP6 gene also became linked to related conditions such as nodular fasciitis, shaping how doctors and pathologists classify these tissue changes today.